WHO ICTRP trial
Randomized, Open-label, Phase III Study Comparing Pemetrexed with and without…
KCT0004170 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0004170 |
|---|---|
| Public title | Randomized, Open-label, Phase III Study Comparing Pemetrexed with and without Carboplatin in Elderly Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer |
| Scientific title | Randomized, Open-label, Phase III Study Comparing Pemetrexed with and without Carboplatin in Elderly Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer |
| Primary sponsor | Asan Medical Center |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Phase3 |
| Countries | Korea, Republic of |
| Conditions | Neoplasms |
| Interventions | Drug : Group A; Pemetrexed pemetrexed 500mg / ? + Carboplatin carboplatin AUC5 every 21 days Group B; Pemetrexed 500mg / ? every 21 days After 4 cycles of treatment with each of the above groups, patients should be treated with pemetrexed… |
| Registration date | Aug 9, 2019 |
| Target size | 266 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: